No. pts (%) | Major bleeding complication | Mild bleeding complication | Severe bleeding complication | p |
---|---|---|---|---|
70 | 22 | 48 | ||
Sex (%) | ||||
Male | 51 (72.9) | 14 (63.6) | 37 (77.1) | 0.240 |
Female | 19 (27.1) | 8 (36.4) | 11 (22.9) | |
Age (years, mean ± SD) | 57.5 (13.7) | 59.3 (13.6) | 56.7 (13.8) | 0.471 |
BMI (kg/m2, mean ± SD) | 22.6 (3.1) | 21.8 (3.1) | 23.0 (3.0) | 0.139 |
Preop creatinine (μmol/L, IQR) | 81.5 (67.8–127.5) | 83.0 (70.5–163.8) | 80.5 (67.0–124.0) | 0.494 |
History of anticoagulation (%) | 3 (4.3) | 2 (9.1) | 1 (2.1) | 0.231 |
Preop clinical (%) | ||||
Pain | 44 (62.9) | 12 (54.5) | 32 (66.7) | 0.330 |
Hematuria | 5 (7.1) | 1 (4.5) | 4 (8.3) | 1.000 |
UTIs | 65 (92.9) | 20 (90.9) | 45 (93.8) | 0.646 |
Preop. comborbidities (%) | ||||
Hypertension | 30 (42.9) | 12 (54.5) | 18 (37.5) | 0.181 |
Diabetes mellitus | 11 (15.7) | 4 (19.0) | 7 (14.6) | 0.725 |
Ischemic heart disease | 14 (20.0) | 6 (27.3) | 8 (16.7) | 0.344 |
Chronic lung disease | 6 (8.6) | 2 (9.1) | 4 (8.3) | 1.000 |
Chronic kidney disease | 23 (32.9) | 7 (31.8) | 16 (33.3) | 0.900 |
At least 1 | 48 (68.6) | 18 (81.8) | 30 (62.5) | 0.106 |
Open surgery history (%) | 11 (15.7) | 6 (27.3) | 5 (10.4) | 0.088 |
History of PCNL (%) | 11 (15.7) | 5 (22.7) | 6 (12.5) | 0.303 |
Calculi side (%) | ||||
Lt | 40 (57.1) | 11 (50.0) | 29 (60.4) | 0.414 |
Rt | 30 (42.9) | 11 (50.0) | 19 (39.6) | |
Stone count (%) | ||||
Single | 20 (28.6) | 7 (31.8) | 13 (27.1) | 0.684 |
Multiple | 50 (71.4) | 15 (68.2) | 35 (72.9) | |
Stone type (%) | ||||
Staghorna | 35 (50.0) | 16 (72.7) | 19 (39.6) | 0.010 |
Others | 35 (50.0) | 6 (27.3) | 29 (60.4) | |
peak Hounsfield unit (Hu, IQR) | 1095.0 (735.0–1406.0) | 1282.0 (723.5–1506.3) | 1086.0 (710.0–1334.0) | 0.425 |
Hydronephrosis (%) | ||||
None or mild | 50 (71.4) | 12 (54.5) | 38 (79.2) | 0.034 |
Moderate or severe | 20 (28.6) | 10 (45.5) | 10 (20.8) |